Interleukin-6 blocker for successful outcome of late-onset rheumatoid oligoarthritis

Journal Title: IP International Journal of Orthopaedic Rheumatology - Year 2017, Vol 3, Issue 1

Abstract

Newer cytokine therapies have revolutionised the management of Rheumatoid arthritis. Atypical oligoarthritis can also be a manifestation of RA and CCP antibodies have been proven to be most specific for Rheumatoid. Our patient had 2 years of painful ankle bilaterally and suggested for joint replacement due to osteoarthritis changes. After the diagnosis of RA using Anti-CCP antibodies, we elected to give Tocilizumab(IL 6 Blocker) which had made the patient to walk without wheelchair after 2 years. This suggests early appropriate diagnosis is the key and Biologics- the new Kid in the market- has proven to be effective in early Rheumatoid arthritis.

Authors and Affiliations

Yuva Vishalini Ravindran, Subramanian Nallasivan

Keywords

Related Articles

Operative Management of closed fracture shaft humerus: comparative study between MIPPO anterior bridge platting Vs conventional ORIF

Aim Operative treatment of shaft humerus fracture continues to evolve MIPPO is one of such emerging operative procedure which does give excellent results over conventional ORIF platting We are comparing overall functiona...

Ultrasound-guided steroid injection: A scintillating dimension in managing de Quervain's tenosynovitis

Introduction de Quervain39s tenosynovitis is a stenosing tenosynovitis of the first extensor compartment of the wrist and leads to wrist pain along with impaired function of the wrist and hand Local steroid injection and...

Fibrodysplasia ossificans progressiva – A rare case

Fibrodysplasia Ossificans Progressiva FOP also known as Myositis Ossificans Progressiva is a very rare and disabling genetic condition characterized by congenital malformation of the great toes with hallux valgus and pro...

Mid-term results of all poly total knee replacement versus metal-back total knee replacement

Background: Osteoarthritis of knee is one of the most common form of arthritis causing degeneration of articular cartilage and subchondral bone. Joint replacement is the gold standard treatment for patients with advanced...

Von Willebrand disease - broadening our vision: a pediatric case report with dental considerations

Von Willebrand disease is an autosomal inherited bleeding disorder caused due to the quantitative or qualitative defects of a multimeric glycoprotein, the Von Willebrand factor (VWF). VWF is a multi-adhesive protein that...

Download PDF file
  • EP ID EP298455
  • DOI 10.18231/2455-6777 .2017.0007
  • Views 66
  • Downloads 0

How To Cite

Yuva Vishalini Ravindran, Subramanian Nallasivan (2017). Interleukin-6 blocker for successful outcome of late-onset rheumatoid oligoarthritis. IP International Journal of Orthopaedic Rheumatology, 3(1), 35-36. https://europub.co.uk/articles/-A-298455